uBriGene Showcases uVivo™ LVV—An IND-Ready In Vivo CAR-T Platform—at ASGCT 2026 Annual Meeting in Boston

uBriGene to Present circRNA-LNP and Lentiviral Manufacturing Innovations at ISCT 2026 in Dublin

uBriGene to Drive Innovation in Cell & Gene Therapy at Advanced Therapies Week 2026 in San Diego

Where Science Meets Strategy: uBriGene Engages Global Leaders at JPM Healthcare Conference 2026

uBriGene to Present High-Yield cGMP Lentiviral Vector Manufacturing Process at the 67th ASH Annual Meeting 2025

uBriGene Biosciences to Showcase End-to-End TIL Manufacturing Innovation at the 7th TIL Therapies Summit in Boston, MA

Meet uBriGene in Philadelphia: Driving the Future of Cell and Gene Therapy at The Advanced Therapies Congress 2025

From LVV Turbo to CAR-TCR Solutions: uBriGene to Showcase Innovation at CAR-TCR Summit 2025 in Boston

Novel sgRNA In Vitro Transcription (IVT) Technology Enhances Gene Editing Efficiency to Debut at the 7th Annual Allogeneic Cell Therapies Summit

uBriGene Heads to ISSCR 2025: Advancing iPSC Innovation on the Global Stage - Booth 907